Chloe Stengel
- Co-authors
- Michael ReedMathew P. LeeseB. V. L. POTTERStephen T. NewmanA. PurohitAtul PurohitSimon P. NewmanPaul Foster
- Topics
- Enzyme function and inhibition (4 papers)Cancer Mechanisms and Therapy (3 papers)Estrogen and related hormone effects (3 papers)
- Partner nations
- United KingdomFranceItaly
In The Last Decade
Chloe Stengel
13 papers receiving 469 citations
Peers
Comparison fields: 5 of 65
- Molecular Biology 271
- Organic Chemistry 180
- Oncology 113
- Genetics 110
- Pathology and Forensic Medicine 73
Countries citing papers authored by Chloe Stengel
This map shows the geographic impact of Chloe Stengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Stengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Stengel more than expected).
Fields of papers citing papers by Chloe Stengel
This network shows the impact of papers produced by Chloe Stengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Stengel. The network helps show where Chloe Stengel may publish in the future.
Co-authorship network of co-authors of Chloe Stengel
This figure shows the co-authorship network connecting the top 25 collaborators of Chloe Stengel. A scholar is included among the top collaborators of Chloe Stengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chloe Stengel. Chloe Stengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX Expression. | 11 |
| 2 | 44 | |
| 3 | 11 | |
| 4 | 39 | |
| 5 | 18 | |
| 6 | 10 | |
| 7 | 25 | |
| 8 | 167 | |
| 9 | 49 | |
| 10 | A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140. | 9 |
| 11 | 41 | |
| 12 | 7 | |
| 13 | 51 |
About Chloe Stengel
Chloe Stengel is a scholar working on Toxicology, Hematology and Cell Biology, having authored 13 papers that have together received 482 indexed citations. Recurring topics across this work include Enzyme function and inhibition (4 papers), Cancer Mechanisms and Therapy (3 papers) and Estrogen and related hormone effects (3 papers). The work is most often cited by research in Organic Chemistry (180 citations), Toxicology (20 citations) and Hematology (47 citations). Chloe Stengel has collaborated with scholars based in United Kingdom, France and Italy. Frequent co-authors include Michael Reed, Mathew P. Leese, B. V. L. POTTER, Stephen T. Newman, A. Purohit, Atul Purohit, Simon P. Newman, Paul Foster, Barry V. L. Potter and Reto Neiger. Their work appears in journals such as Chemical Communications, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.